SouthState’s Atrium Therapeutics RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17 Buy
+2
New +$24 ﹤0.01% 1375

Other funds holding RNA

SouthState's RNA Position: Q3 2026 in Review

SouthState opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 2 shares worth $17. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings.

96 funds tracked by Wall St. Rank hold RNA as of Q3 2026.

  • SouthState held 2 shares of Atrium Therapeutics worth $17 as of Q3 2026.
  • Atrium Therapeutics was a new SouthState position in Q3 2026.
  • Atrium Therapeutics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1375 holding.
  • 96 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.